This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
DuPont (DD) Completes Four Clean Water Technology Buyouts
by Zacks Equity Research
DuPont's (DD) acquisition of four clean water technologies is in sync with its strategy of becoming the leading water technology supplier to better serve changing customer needs globally.
Will DuPont (DD) Witness Turbulence in the Next Year Too?
by Namrata Chatterjee
A challenging global economic scenario and soft end-market demand due to the trade war have kept DuPont's (DD) stock under pressure.
DuPont Exercises Option to Acquire 100% Ownership of OxyMem
by Zacks Equity Research
DuPont's (DD) MEMCOR MBR product and MABR technology offer more solutions for customers seeking to reduce footprint and energy requirements for secondary wastewater treatment.
International Flavors (IFF) Seals Merger Deal With DuPont Arm
by Zacks Equity Research
International Flavors' (IFF) merger deal to create a leading company in high-value ingredients and solutions for food and beverage, home and personal care, and health & wellness markets.
DuPont (DD) Scoops Up Desalitech, Strengthens Portfolio
by Zacks Equity Research
The buyout reinforces DuPont's (DD) portfolio with a compelling offering to further minimize the lifecycle cost of water purification and reuse.
Here's Why You Should Hold Onto DuPont (DD) Stock for Now
by Zacks Equity Research
DuPont (DD) benefits from cost-control actions and product launches amid headwinds from soft demand and currency.
Chemical Stock Earnings Due on Nov 7: APD, ESI, TROX & ICL
by Anindya Barman
Let's take a look at how these chemical companies are poised ahead of their earnings release.
DuPont (DD) Beats on Q3 Earnings & Sales, Narrows EPS View
by Zacks Equity Research
DuPont (DD) gains from higher pricing, portfolio actions and cost control amid a challenging macroeconomic environment in Q3.
DuPont's (DD) Q3 Earnings and Sales Beat Estimates
by Zacks Equity Research
DuPont's (DD) Q3 adjusted earnings of 96 cents per share surpassed the Zacks Consensus Estimate of 95 cents.
DuPont (DD) Gears Up for Q3 Earnings: What's in the Cards?
by Zacks Equity Research
Soft demand is expected to have impacted DuPont's (DD) organic sales in the third quarter.
DuPont to Acquire Memcor Membrane Product Line From Evoqua
by Zacks Equity Research
The buyout is in sync with DuPont's (DD) commitment to invest in specialty solutions aligned with attractive, high-growth end markets.
DuPont (DD) to Buy BASF's Ultrafiltration Membrane Business
by Zacks Equity Research
The buyout will add to DuPont's (DD) portfolio of water purification and separation technologies, expanding its water purification capabilities.
Top Research Reports for Target, Illumina & T-Mobile US
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Target (TGT), Illumina (ILMN) and T-Mobile US (TMUS).
Should You Invest in the Fidelity MSCI Materials Index ETF (FMAT)?
by Zacks Equity Research
Sector ETF report for FMAT
DuPont to Sell Silicon Carbide Wafer Business to SK Siltron
by Zacks Equity Research
The divestment is in sync with DuPont's (DD) strategy of active portfolio management.
Is DuPont de Nemours (DD) a Great Pick for Value Investors?
by Zacks Equity Research
DuPont de Nemours (DD) stock may be a good choice for value-oriented investors right now from multiple angles.
DuPont's (DD) Earnings Top, Sales Trail Estimates in Q2
by Zacks Equity Research
DuPont (DD) gains from cost and pricing actions in Q2. The company raises adjusted earnings per share guidance for 2019.
DuPont's (DD) Q2 Earnings Beat Estimates, Revenues Miss
by Zacks Equity Research
DuPont's (DD) Q2 adjusted earnings of 97 cents per share topped the Zacks Consensus Estimate of 86 cents.
DuPont (DD) Warms Up to Q2 Earnings: What's in the Offing?
by Zacks Equity Research
Our proven model does not show that DuPont (DD) is likely to beat estimates this quarter.
Should You Invest in the Fidelity MSCI Materials Index ETF (FMAT)?
by Zacks Equity Research
Sector ETF report for FMAT
Analysts Estimate DuPont (DD) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
DuPont (DD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why DuPont (DD) Could Be Positioned for a Slump
by Zacks Equity Research
DuPont (DD) has witnessed a significant price decline in the past four weeks, and is seeing negative earnings estimate revisions as well.
New Strong Sell Stocks for June 6th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today.
DuPont Launches EverpreX Soybean Herbicide to Protect Crops
by Zacks Equity Research
DuPont (DD) introduces EverpreX herbicide, a crop protection solution to fight resistant weeds for safeguarding yield protection.
Monsanto's Tech Improvements to Boost Innovation Platform
by Zacks Equity Research
Monsanto (MON) offers advanced Climate FieldView platform and NemaStrike technology for 2018 crop season. It intends to supply more Roundup Ready 2 Xtend soybeans in the United States.